Fig. 5
From: A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer
The THR signatures are enriched in ER, AR, and immune pathways in gene set variation analysis (GSVA). A Heatmap showing the Spearman correlation coefficients between different breast cancer signatures (rows) and key cancer-associated pathways and biological processes (columns). Positive correlation (red), negative correlation (blue), p-value < 0.05 (*), false discovery rate (FDR) < 0.05 (#). B Immune cell type enrichment score heatmap (rows) in different breast cancer signatures (columns). Positive enrichment (red) and negative enrichment (blue)